ReviewFrontiers in oncology2022

When cancer drug resistance meets metabolomics (bulk, single-cell and/or spatial): Progress, potential, and perspective.

Zhiqiang Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.